Related by context. All words. (Click for frequent words.) 66 Lock Loop PLL 65 Bayer HealthCare Onyx Pharmaceuticals 64 Population Enumeration 63 IIa clinical 63 BRIM2 62 #DF [001] 62 Phase Ib study 61 confirmatory pivotal 61 Huaiyin Power Plant 60 Phase IIB 60 Phase Ib II 60 Prostate AdenoCarcinoma Treatment 60 IIa trial 59 Phase 1a clinical 59 IIa clinical trials 58 Phase Ib clinical 58 BRIM3 58 IMPACT IMmunotherapy 58 bavituximab monotherapy trial 58 GALNS 58 SUCCEED trial 58 bapineuzumab AAB 58 phase Ib 58 Phase 1a 58 IIa trials 58 NO# [002] 58 phase IIa 58 transmucosal delivery system 57 MEND CABG II 57 HuMax EGFr 57 VALOR trial 57 initiate multicenter 57 phase IIb 57 Diamyd r vaccine 57 ORAL Solo 57 JunJing II 57 detailed geologic mapping 57 SYMMETRY trial 57 BLA filing 56 clinic automation LabPas 56 pixantrone NDA 56 confirmatory clinical 56 Phase II 56 XL# SAR# 56 European Sepsis Trial 56 Phase lll 56 multicentre randomized 56 PSMA ADC 56 Quinamed 56 Testosterone MDTS ® 56 multicenter randomized placebo controlled 56 Ground geophysical surveys 56 GAMMAGARD 56 Truvada tablets 56 mertansine 56 X PECT trial 56 Glufosfamide 56 LUX Lung 55 Elagolix 55 Phase #b/#a 55 PRE SURGE 55 R#/MEM # 55 Phase1 55 multicenter dose escalation 55 pivotal bioequivalence 55 Phase IIa trials 55 GLP toxicology studies 55 multicenter Phase 55 CHAMPION PCI 55 Phase IIb trials 55 AERAS-#/Crucell Ad# 55 Phase 55 phase IIa clinical 55 Clabber Creek 55 randomized controlled Phase 55 Solorel 55 CLIRS trial 55 PRECISE Trial 55 TG# [001] 55 ACCLAIM II 55 Phase 1b 54 Phase III 54 Airborne geophysical surveys 54 IND submission 54 PN# [001] 54 OncoVEX GM CSF 54 Phase IIIb clinical 54 treatment naive genotype 54 NCIC CTG 54 Aplidin R 54 CAMMS# 54 assessing T DM1 54 torezolid phosphate 54 Randomized Phase II 54 CAM# 54 elotuzumab 54 Exherin TM 54 IMPACT DCM 54 ADVANCE PD 54 ICESS 54 OPT CHF 54 Actilon 54 Multiple Ascending Dose 54 Honeywell Experion 54 dose escalation phase 54 OncoGel 54 randomized controlled multicenter 54 non nucleoside HCV 54 riociguat 54 trastuzumab emtansine T DM1 54 Orbit Validation 54 IMC #B 54 OLYMPIA registry 54 EXPLORE Xa 54 CBLC# 54 Thorough QT Study 54 alvespimycin 54 PFO migraine 53 bazedoxifene conjugated estrogens 53 AMPAKINE CX# 53 Q#IR 53 budesonide foam 53 Phase 2b study 53 MEND CABG 53 AeroLEF TM 53 Phase 2b trial 53 JZP 53 Phase #/#a 53 infill sampling 53 evaluating mipomersen 53 Bedard Dyke 53 Schematic Design 53 MVax 53 Dose escalation 53 extraction SPE 53 TEMSO 53 Phase 1b clinical trials 53 PEARL SC 53 PANVAC VF 53 blinded randomized placebo controlled 53 Xanafide 53 ASA# 53 oral methylnaltrexone 53 stope preparation 53 dose escalation Phase 53 Phase 2a trial 53 mg/m2 cohort 53 Testosterone MDTS R 53 LUMINATE 53 COSIRA trial 53 examining REOLYSIN 53 pharmacokinetic PK 53 ACAPODENE 53 randomized discontinuation 53 MAQC 53 YONDELIS 53 Confirmatory Phase 53 Phase 1b Clinical Trial 53 STRIDE PD 53 TMC# C# 53 delineation drill 53 confirmatory Phase III 53 Medullary Thyroid Cancer 53 Phase Ib 53 phase IIb study 53 NABTT 52 unblinding 52 include Ischemic Paraplegia 52 Bohol Irrigation 52 farletuzumab 52 ENRICH trial 52 Prefeasibility 52 registrational trial 52 Phase 2b monotherapy 52 Study #CL# 52 initiate Phase IIb 52 relapsed MCL 52 Phase 2a clinical trials 52 CDAD Clostridium difficile 52 BCX# 52 TBC M4 52 #.#Mlb pa 52 Dose Escalation 52 PREOS R 52 airborne geophysical surveying 52 Carb Controller 52 multicenter Phase II 52 STP McKay Thermal 52 Aurora kinase inhibitor 52 HEPLISAV ™ 52 SNT MC# 52 VTEM airborne surveys 52 Phase IIb III 52 dose escalation trial 52 hydraulic fracture stimulation 52 OLpur TM H2H 52 GRAVITAS trial 52 NP2 Enkephalin 52 severe oral mucositis 52 Pilanesberg Project 52 designated HVTN 52 dependent kinase inhibitor 52 Sapacitabine 52 ENDEAVOR IV 52 magnetic geophysical surveys 52 CATIE AD 52 HPTN 52 APEX PD 52 Dyloject TM 52 ToxCast TM 52 REVIVE TA 52 pharmacokinetic PK study 52 CVac 52 HCV SPRINT 52 huN# DM1 52 II SBIR 52 Telatinib 52 REG2 52 D#B 52 resminostat 52 studies evaluating satraplatin 52 ixabepilone 52 ATAC Arimidex Tamoxifen Alone 52 HGS# 52 BrachySil 52 Phase III Clinical Trials 52 DLTs 52 Archexin 52 placebo controlled Phase 52 phase IIb clinical 52 palifosfamide Zymafos TM 52 Non Aqueous 52 LB# [003] 52 multicenter randomized controlled 52 HuMax Wnt 52 PrevOnco ™ 52 thorough QT 52 HZ# 52 ILLUMINATE 52 Phase IIA 52 subcutaneous PRO 52 Rigel R# 52 HCV RESPOND 2 52 rotary VAD 52 R roscovitine 52 Phase #/#a clinical 52 Degarelix 52 VICTOR E1 52 MIVI TRUST 52 phase Ib clinical 52 NOR Flash NAND Flash 52 CCX# 52 Diamyd Medical Diamyd 52 3 registrational trial 52 VITAL Trial 52 Phase III HEAT 52 Metallurgical testwork 52 Pre RELAX AHF 52 Allovectin 7 52 trastuzumab DM1 T DM1 52 Prodarsan ® 52 recombinant PSMA vaccine 52 APTIVUS 52 Zensana TM 52 multiple ascending dose 51 human microdosing 51 TMC# [002] 51 Oluvil Port 51 Bankable Feasibility Study BFS 51 dose escalation clinical 51 Phase 2b Study 51 RhuDex 51 placebo controlled clinical 51 Phase 2b clinical 51 Canariaco Norte copper 51 Oral NKTR 51 CRMD# 51 phase IIb trial 51 oral ridaforolimus 51 NEO3 51 geochemical surveying 51 ABSORB clinical 51 lock loop PLL 51 Randomized Phase 51 Initiated Phase 51 SPIRIT FIRST 51 Albuferon Phase 51 Dacogen injection 51 BIBW 51 Enters Beta 51 rALLy clinical trial 51 inferred resource calculation 51 Initiate Phase 51 Lockerby Depth 51 generation purine nucleoside 51 confirmatory Phase 51 forodesine 51 ALPHADAS 51 BiTE R 51 albiglutide 51 oral RELISTOR 51 Fracture stimulation 51 vascular disrupting agent 51 ALSYMPCA 51 EM geophysical survey 51 oral picoplatin 51 dosing cohort 51 Dose Ranging 51 induced polarization geophysics 51 lorcaserin Phase 51 ChronVac C ® 51 Phase IIIb 51 prospecting trenching 51 2Mtpa 51 opioid induced bowel dysfunction 51 AVADO 51 Azedra 51 Anuri kimberlite 51 Syncria albiglutide 51 prefeasibility 51 MADIT II 51 PCI ExTRACT TIMI 51 NET# [002] 51 BLA submission 51 DEB# 51 ADMIRE HF 51 ABSORB trial 51 NFFWP 51 Kyzyloi Field 51 Syllego system 51 FORTIS M 51 3D Induced Polarization 51 Randomised 51 PROLACRIA 51 OX2 engine 51 Pinglu Project 51 Hsp# Inhibitor 51 DermaVir Patch 51 rPA anthrax vaccine 51 Plaza Sentral 51 Genz # 51 overactive bladder AA# 51 EPA ToxCast 51 PRIMO CABG 51 trastuzumab DM1 51 Zemplar Capsules 51 phase 2a 51 RE SURGE 51 ToxCast 51 Lucanix R 51 Prefeasibility Study 51 Oncotype DX colon cancer 51 Heap Leach Project 51 Pivotal Phase 51 neratinib 51 IMA# 51 Pharmacokinetic PK 51 Allovectin 7 R 51 budesonide MMX Phase III 51 inhaled AAT 51 TotalView Debugger 51 VentriPoint Diagnostic System 51 Inata Gold 51 OSV Newbuild Program 51 RSD# oral 51 Thorough QT 51 Phase 2b clinical trials 51 BLOOM Behavioral modification 51 CopperProof 2 51 IP Resistivity survey 51 km2 3D seismic 50 multicenter randomized Phase 50 Phase Ib Clinical Trial 50 Universal Flu Vaccine 50 randomized Phase IIb 50 Phase 1b clinical 50 HCD# [002] 50 CG# oncolytic virus 50 rALLy trial 50 Content Encounter 50 TRC# 50 HuLuc# 50 Allovectin 7 ® 50 REVIVE Diabetes 50 Phase III randomized controlled 50 brivaracetam 50 Phase 2a clinical 50 ARDIS 50 PMA submission 50 GCP compliant 50 Cardio3KG 50 IIa Clinical Trial 50 florbetaben 50 FileWorks Online 50 Ocrelizumab 50 feasibilty study 50 PrevOnco 50 Fx #A 50 borehole EM 50 Downtown Streetscape 50 multicenter phase 50 randomized Phase 2b 50 LUVENIQ 50 Lung Cancer Trial 50 Dual Voltage 50 anti HGF antibody 50 ToGA 50 Phase #b/#a clinical 50 magnetometric 50 Trastuzumab DM1 50 Feasibility Trial 50 blinded randomized 50 IMC A# 50 evaluating satraplatin 50 LCP AtorFen 50 Proellex TM 50 IIb clinical trial 50 Medidur TM FA 50 Phase IIa clinical trials 50 tramiprosate Alzhemed TM 50 UPLYSO 50 initiate Phase 1b 50 TASKi3 50 Novolimus 50 albiglutide currently 50 registrational 50 DXL# 50 DAC HYP 50 bevirimat Study 50 Operational Evaluation 50 Fodosine 50 IP induced polarization 50 Definition Drilling 50 TASKi2 50 pertuzumab 50 cGMP manufacture 50 CAPACITY trials 50 CUSTOM III 50 Phase III Pivotal 50 geophysical geochemical 50 tpd throughput 50 including eniluracil ADH 50 Targretin capsules 50 Hedgehog antagonist 50 SIMPADICO 50 KB# [002] 50 NADiA ProsVue 50 Phase III ThermoDox 50 AP# [003] 50 registrational Phase 50 Phase IIb trial 50 Goldcrest Dreams 50 Genasense oblimersen sodium Injection 50 confirmatory Phase 3 50 Cloretazine R VNP#M 50 Integral Systems EPOCH IPS 50 #:# randomization 50 Pralatrexate 50 CAPRI TM 50 Imvamune R 50 Tesetaxel 50 excavator trenching 50 mapping geochemical sampling 50 ZALBIN dosed 50 Beyondie Project 50 Sindesar Khurd mine 50 Proxinium TM 50 geochemical geophysical 50 bardoxolone 50 QTinno TM 50 Induced polarization 50 Eniluracil 50 Confirmatory 50 Marillana 50 NDA resubmission 50 Phases II 50 MAGE A3 ASCI 50 TOF TOF 50 GV# [001] 50 samalizumab 50 clinical trials Multikine 50 Taysan Copper Gold 50 Phase 2a 50 PENNVAX B 50 kilometer 2D seismic 50 GetGoal Phase III 50 Pivotal Trial 50 PMSSY 50 PA# [002] 50 ozarelix 50 eZ# RF# 50 AKT inhibitor 50 interferon beta 1b 50 custirsen 50 reconnaissance mapping 50 4SC commented 50 Curaxin CBLC# 50 OXi# 50 FDA Investigational Device 50 clinical trials Archexin 50 aircore drilling 50 ground geophysical surveying 50 Phase III VISTA 50 CIMZIA ™ 50 maximally tolerated dose 50 SAR# [004] 50 Equalizer VLB 50 OvaRex ® MAb 50 Trofex 50 Vicor anticipates 50 IP geophysical surveys 49 PDE4 inhibitor 49 ganetespib 49 generation URAT1 inhibitor 49 ANCHOR trial 49 generation rotary VAD 49 tramiprosate ALZHEMED TM 49 Phase Ia 49 Certej Project 49 SX EW plant 49 PRESEPT 49 paclitaxel poliglumex 49 Phase #b/#a trial 49 Clinicaltrials.gov 49 octreotide implant 49 Acetavance TM intravenous acetaminophen 49 #.#ap 49 Exelixis XL# 49 eltrombopag 49 Ozarelix 49 pharmacodynamic PD 49 Plicera 49 Gentamicin Surgical Implant 49 GLP1 agonist 49 pain palliation 49 Tuberculosis Vaccine 49 orBec 49 StemEx 49 Neuvenge 49 TAXUS IV 49 Ling'ao 49 BLEG sampling 49 Zerenex Phase 49 cannabinor 49 evaluating RDEA# 49 ACTIVE W 49 JORC resource estimate 49 TKB# 49 Urocidin 49 BeadXpress 49 PROSTVAC TM 49 eliglustat tartrate 49 release cysteamine bitartrate 49 Mansker Farms 49 #km 2D seismic 49 dosing cohorts 49 file INDs 49 intravenous methylnaltrexone 49 Annamycin 49 Cancer Vaccines 49 NMT Medical Announces 49 Prodarsan 49 trodusquemine 49 EMPOWER Study 49 randomized multicentre 49 DSMB recommended 49 flowsheet 49 Ofatumumab 49 Zenvia Phase III 49 Phenoptin 49 EndoTAG TM -1 49 MegaTEM 49 lintuzumab 49 axitinib 49 JunJing III 49 Simuku 49 TSX PTQ OTCBB PTQMF 49 Dahej LNG terminal 49 Anturol TM 49 Dextofisopam 49 CR# vcMMAE 49 IMGN# 49 ASCO Abstract 49 tolevamer 49 initiate Phase 2b 49 Sym# 49 tiapamil 49 Medidata Designer 49 EGS# 49 JORC compliant resource 49 Phase IIIb study 49 Huntexil 49 CRLX# 49 mapping prospecting 49 cathepsin K inhibitor 49 NG BASS 49 preliminary cyanide amenability 49 SBIR Grant 49 Mirbat Beach 49 Cloretazine 49 ACC5 49 SBIR Phase 49 vidofludimus 49 1Mtpa 49 Crocette 49 relapsed MM 49 Phase III Clinical Trial 49 IMPACT DCM clinical 49 Bulk sampling 49 evaluating satraplatin plus 49 flotation testwork 49 unique alkylating agent 49 locked loop PLL 49 randomized controlled clinical 49 Chidliak exploration 49 Glybera R 49 TSX VENTURE RPX 49 Reverse Circulation 49 BCIRG 49 Aplidin 49 ADAGIO study 49 Managed Motorways 49 preclinical efficacy 49 tezampanel NGX# 49 Handcamp property 49 Surfaxin LS 49 cancer neuroendocrine tumor 49 Product candidate Serada 49 Premarket Approval 49 Phase IIa proof 49 Traumatic Spinal Cord Injury 49 Luiri Hill 49 Phase IIb clinical trials 49 budesonide MMX 49 LGS 3D 49 BrachySil TM 49 Zevalin consolidation 49 ongoing Phase 1b 49 RIBBON 49 MERLIN TIMI 49 Systemic Delivery 49 CYT# potent vascular disrupting 49 Sage SalesLogix Cloud 49 Feasibility Studies 49 Phase 1b dose escalation 49 omacetaxine mepesuccinate 49 seasonal influenza VLP vaccine 49 Quartus R 49 receptor tyrosine kinase inhibitor 49 denosumab oncology 49 Luveniq 49 Phase III metastatic melanoma 49 docetaxel Taxotere R 49 INCB# [001] 49 Ceplene/IL-2 49 UVIDEM 49 IP Resistivity 49 nab paclitaxel 49 Orosi Mill project 49 seismic reprocessing 49 NVA# 49 Resource Calculation 49 Sisson Brook 49 Tarceva TM 49 Randomized Evaluation 49 Angiogenic 49 Pfizer maraviroc 49 SAGD Phase 49 Fractional N 49 Phase Ib IIa 49 evaluating T DM1 49 BEZ# 49 Saforis 49 ZTEM survey 49 Cadence Virtuoso custom 49 Ling Ao 49 subcutaneous Herceptin 49 MOZOBIL 49 var arrContent = 49 tanespimycin 49 Phase III TRIST 49 TLK# 49 km 2D seismic 49 oral deforolimus 49 var arrUrl = 49 RenalGuard System TM 49 Lauterbach TRACE# 49 Kinsevere mine 49 MoxDuo ® 49 initiated Phase Ib 49 Cardiotoxicity 49 EDEMA4 48 PROTECT AF 48 borehole electromagnetic 48 OMS#HP 48 DDP# 48 MTPS 48 IIIb 48 Neo Kidney Augment 48 metastatic hormone refractory 48 JDRF Artificial Pancreas 48 Traficet EN 48 South Tchibala 48 solithromycin 48 Luramist TM 48 Campamento Deposit 48 Clinical Trial Evaluating 48 randomized multicenter trial 48 Phase Ib clinical trials 48 canagliflozin 48 GATTEX ® 48 resource delineation drilling 48 unblind 48 ASONEP 48 Kinesin Spindle Protein KSP 48 TransVax ™ 48 Guanilib 48 SmartPlant Enterprise solutions 48 comparing alemtuzumab 48 midstage trials 48 Brimstone leach pad 48 Phase IIb 48 biologic DMARD 48 dose escalation 48 feasability study 48 phase IIb III 48 manufactures fluorescent lighting 48 JORC Code compliant 48 #mb PowerBook G4 48 paste backfill 48 Feasibility Study FS 48 PI3K/Akt pathway inhibitor 48 overburden characterization 48 randomized Phase III 48 IIa clinical trial 48 CML CP 48 HuMax CD4 48 DOM Level 48 balsalazide tablet 48 IV RSD# 48 Vitaxin 48 pole dipole 48 CEQ# 48 Lovaxin C 48 metallurgical flowsheet 48 alpha 2A adrenoceptor 48 AIR CF2 48 LymphoStat B TM 48 Geotechnical drilling 48 aircore 48 exome capture 48 ZACTIMA 48 EchoCRT 48 TSQ Quantum 48 LibiGel NDA 48 Kangaluwi 48 clinicaltrials 48 Clinical Outcome 48 PF # [001] 48 PRIMO CABG2 48 Enzastaurin 48 eCRF 48 DiCOM 48 Bayesian statistical 48 SEPET TM 48 Confirmatory testing 48 var arrMeta = 48 IP geophysical 48 Initiate Phase II 48 RG# [001] 48 tesmilifene 48 pharmacokinetic PK profile 48 Tyrima 48 Titan# 48 Pivotal Phase III 48 Hemodiafiltration 48 HDACi 48 pharmacodynamic effects 48 Bankable Feasibility Study 48 MDS AML 48 GITEWS 48 EV DO Rev.B 48 Enhanze Technology 48 hGH CTP Phase 48 iSIGHT FD 48 AEG# 48 dexpramipexole 48 ALISTA TM 48 PEGylated interferon 48 methylnaltrexone 48 Starter Pit 48 Phase III psoriasis 48 ENGAGE AF TIMI 48 Curipamba Project 48 Shire velaglucerase alfa 48 velafermin 48 double blinded randomized 48 ONCONASE R 48 resource delineation 48 gemcitabine Gemzar ® 48 clinical pharmacology studies 48 includes Prototype Demonstration 48 rindopepimut 48 MelaFind pivotal 48 PhG alpha 1 48 Loetschberg tunnel 48 orally dosed 48 SelfReliant 48 drug pipeline TAFA# 48 cortical stimulation 48 Phase III Psoriasis 48 Induced Polarisation 48 induced polarization geophysical 48 Patient Enrolment 48 Kahalalide F 48 Pharmacokinetic Study 48 lead Aganocide compound 48 geochemical assay 48 dose cohort 48 EDEMA3 48 ALN HTT 48 NSABP B 48 II Clinical Trial 48 selective androgen receptor modulator 48 deforolimus 48 platinum refractory 48 PRECiSE 48 FRANKFURT P7Z 48 zileuton CR 48 Evaluation Module 48 Phase IIa trial 48 sapacitabine 48 CytoFabTM 48 Watson LIMS 48 preclinical toxicology 48 EOquin TM 48 Diamyd r 48 galiximab 48 PEG SN# 48 Clinical Trial Results 48 relapsed refractory multiple myeloma 48 PEG PAL 48 CIMZIA TM 48 Interferon Gamma 48 Tsining JunJing II 48 Cyclone Risk Mitigation 48 MPEH TM 48 Asgi 48 geological mapping trenching 48 Bioral Amphotericin B 48 LO LOESTRIN FE 48 FDG-PET/CT 48 Omnitarg 48 NDA Submission 48 maribavir 48 Roughrider Uranium Deposit 48 Rodnikovskogo 48 Perkoa 48 Lobito Tomboco 48 dirucotide 48 alvimopan 48 OncoVEX 48 Rainee Canal 48 Xilinx ISE 48 RIGScan CR 48 Immunotherapeutic 48 Phase III placebo controlled 48 SparVax TM 48 CTA# Injection 48 Plaque Psoriasis 48 Urumalqui Au Ag 48 Study Evaluating 48 Phase III confirmatory 48 GPS IIIA satellite 48 Greystone Subdivision 48 ospemifene 48 novel oral anticoagulant 48 Ostarine 48 N2 Gateway Housing 48 multicenter randomized clinical 48 metastatic RCC 48 demonstration SDD 48 TBC# 48 generation HCV protease 48 Cloretazine ® 48 PegIFN 48 Recurrent Glioblastoma 48 process flowsheet 48 MEK inhibitor RDEA# 48 surface geochemical sampling 48 granted Ortec 48 backhoe trenching 48 ATL# [001] 48 Bonanza Ledge 48 ARIKACE 48 Phase 2a Trial 48 label multicenter randomized 48 MIST II 48 Feasibility Report 48 CCR2 receptor 48 recurrent glioma 48 El Colmillo Gold 48 Phase IIb Trial 48 Pivotal Phase II 48 Aurora Kinase 48 LDRA Testbed 48 PRT# 48 Ground geophysics 48 underground delineation drilling 48 Anti CD# Antibody 48 underground longwall mining 48 Cimzia TM 48 Klocwork Insight 48 PRESEPT study 48 Aflibercept 48 Phase 2b randomized 48 R#/MEM 48 Combination Clinical Trial 48 Piedras Verdes Mill 48 Phase IIa clinical 48 initiate Phase IIa 48 RESTORE CLI trial 48 NG BOSS 48 oral prodrug 48 double blinded placebo 48 soil geochemical sampling 48 Peptide Synthesis 48 Custirsen 48 ADVENT 48 Kemetco 48 Pendalian 48 Veeco Labs 48 Pre Feasibility 48 fostamatinib 48 seliciclib CYC# 48 2D Seismic 48 aurora kinase 48 Dose Ranging Study 48 phase IIIb 48 SPRIX ® 48 investigational protease inhibitor 47 VP# [004] 47 IND enabling 47 Bosentan 47 vernakalant hydrochloride 47 SCENESSE ® 47 BIOX R 47 tenofovir disoproxil fumarate Viread 47 NGX# 47 ImmunoVEX HSV2 47 Zerenex ™ 47 Bechara findings 47 Multicenter Randomized 47 TransVax tm 47 CELVAPAN H#N# 47 DASISION 47 tremelimumab 47 Preliminary metallurgical 47 HuMax CD# 47 PRECISE trial 47 3Mtpa 47 PF # [002] 47 Spiegelmer ® 47 IIb 47 Kaunisvaara Iron Concentrate 47 Antibody Drug Conjugate 47 Alzhemed TM 47 Induced Polarization geophysical 47 evaluating Actimmune 47 auger drill 47 SDD phase 47 Airborne Geophysical 47 velaglucerase alfa 47 Clinical Trial Data 47 Breast Density 47 prospecting geological mapping 47 PROMACTA 47 BAY #-# 47 oral rivaroxaban 47 vivo glucose 47 PSDM 47 Accelerated Feasibility Study 47 mITT population 47 WK# [001] 47 M Vax 47 trans urethral resection 47 ROM pad 47 clinical trial 47 HGS ETR1 47 HOUSE Remains 47 StemEx R 47 vitro ADME 47 FlexFactory 47 GED aPC 47 selectin antagonist 47 VEGFR2 inhibitor 47 CLL8 47 Al Sufouh Tram 47 ASCT